Dolby Laboratories Reports Third Quarter 2024 Financial Results

SAN FRANCISCO, Aug. 7, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2024.

"Our third quarter results were in line with expectations," said Kevin Yeaman, President and CEO, Dolby Laboratories. "This quarter we continued to build momentum for the content available in Dolby Vision and Dolby Atmos, especially in sports, with viewers around the world enjoying the T20 Cricket World Cup, UEFA EURO 2024, Wimbledon, the NHL and NBA post seasons and right now, the Olympics in Dolby."

Third Quarter Fiscal 2024 Financial Highlights

    --  Total revenue was $288.8 million, compared to $298.4 million for the
        third quarter of fiscal 2023.
    --  GAAP net income was $38.4 million, or $0.40 per diluted share, compared
        to GAAP net income of $16.4 million, or $0.17 per diluted share, for the
        third quarter of fiscal 2023. On a non-GAAP basis, third quarter net
        income was $68.8 million, or $0.71 per diluted share, compared to $54.1
        million, or $0.55 per diluted share, for the third quarter of fiscal
        2023.
    --  Dolby repurchased approximately 423,000 shares of its common stock and
        ended the quarter with approximately $72 million of stock repurchase
        authorization available going forward.

A complete listing of Dolby's non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.

Recent Business Highlights

    --  Cadillac announced the 2025 OPTIQ EV with Dolby Atmos.
    --  Electric automotive manufacturer Rivian launched the second generation
        of its flagship vehicles, the R1S SUV and R1T pickup, that feature
        support for Dolby Atmos.
    --  Great Wall Motors launched its new smart cabin system, Coffee OS 3, and
        a new automobile model with Dolby Atmos.
    --  Transsion added a Dolby enabled low cost phone for consumers in
        Malaysia.
    --  Sharp Singapore launched the R8s Pro smartphone series with Dolby Vision
        and Dolby Atmos.
    --  Realme launched the GT6, the first smartphone to support Dolby Vision
        video capture in telephoto video.
    --  The T20 Cricket World Cup, UEFA EURO 2024, Wimbledon, and the NHL and
        NBA post seasons were all available in Dolby Atmos and Dolby Vision.
    --  Comcast announced that the 2024 Olympics coverage will be available in
        Dolby Vision and Dolby Atmos.
    --  Sonos launched headphones that support Dolby Head Tracking with Dolby
        Atmos.
    --  VIZIO announced integration of Dolby Atmos across its entire 2024
        soundbar lineup.
    --  Lenovo launched several new flagship products that support Dolby Vision
        and Dolby Atmos - including the Yoga Air, moto razr, and moto S50 Neo.
    --  Melco Resorts & Entertainment opened Studio City Cinema, which is the
        first Dolby Cinema in the Hong Kong Macau Region.

Dividend

Today, Dolby announced a cash dividend of $0.30 per share of Class A and Class B common stock, payable on August 27, 2024, to stockholders of record as of the close of business on August 19, 2024.

Stock Repurchase Program

Today, Dolby also announced that its Board of Directors has approved increasing the size of its stock repurchase program by $350 million, bringing the amount available for future repurchases of its Class A Common Stock to approximately $422 million. Stock repurchases under this program may be made through open market transactions, negotiated purchases, or otherwise, at times and in amounts that the company considers appropriate.

Financial Outlook

Dolby's financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the estimates Dolby is providing below due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates. The uncertainty resulting from these factors has greatly reduced its visibility into Dolby's future outlook. To the extent possible, the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see "Forward-Looking Statements" in this press release for a description of certain risks that Dolby faces, and the section captioned "Risk Factors" in its Quarterly Report on Form 10-Q for the third quarter of fiscal 2024, to be filed on or around the date hereof.

Dolby is providing the following estimates for its fourth quarter of fiscal 2024:

    --  Total revenue is estimated to range from $300 million to $320 million.
    --  Licensing revenue is estimated to range from $275 million to $295
        million.
    --  Gross margins are anticipated to be approximately 88%.
    --  Operating expenses are anticipated to range from $225 million to $235
        million on a GAAP basis and from $190 million to $200 million on a
        non-GAAP basis.
    --  Effective tax rate is anticipated to be around 29% on a GAAP basis and
        around 23% on a non-GAAP basis.
    --  Diluted earnings per share is anticipated to range from $0.31 to $0.46
        on a GAAP basis and from $0.61 to $0.76 on a non-GAAP basis.

Dolby is providing the following estimates for the full year of fiscal 2024:

    --  Total revenue is expected to range from $1.27 billion to $1.29 billion.
    --  Gross margins are anticipated to be roughly 89%.
    --  Operating expenses are anticipated to range from $875 million to $885
        million on a GAAP basis and from $735 million to $745 million on a
        non-GAAP basis.
    --  Dolby expects operating margins on a GAAP basis to be roughly 20% and on
        a non-GAAP basis to be roughly 31%.
    --  Diluted earnings per share is anticipated to range from $2.40 to $2.55
        on a GAAP basis and from $3.60 to $3.75 on a non-GAAP basis.

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss third quarter fiscal 2024 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Wednesday, August 7, 2024. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-210-2212 (+1-646-960-0390 for international callers) and entering confirmation code 5587811.

A replay of the call will be available from 5:00 p.m. PT (8:00 p.m. ET) on Wednesday, August 7, 2024, until 8:59 p.m. PT (11:59 p.m. ET) on Wednesday, August 14, 2024 by dialing 1-800-770-2030 (+1-647-362-9199 for international callers) and entering the confirmation code 5587811. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.

Non-GAAP Financial Information

To supplement Dolby's financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations and performance. We believe these non-GAAP financial measures are also helpful to investors in enabling comparability of operating performance between periods and among peer companies. Additionally, Dolby's management regularly uses our supplemental non-GAAP financial measures to make operating decisions, for planning and forecasting purposes and determining bonus payouts. Specifically, Dolby excludes the following as adjustments from one or more of its non-GAAP financial measures:

Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that Dolby grants. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between its underlying operating results and those of other companies, Dolby excludes stock-based compensation expense.

Amortization of acquisition-related intangibles: Dolby amortizes intangible assets acquired in connection with business combinations. These intangible assets consist of patents and technology, customer relationships, and other intangibles. Dolby records amortization charges relating to these intangible assets in its GAAP financial statements, and Dolby views these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of its acquisitions. As these amortization charges do not directly correlate to its operations during any particular period, Dolby excludes these charges to facilitate an evaluation of its current operating performance and comparisons to its past operating results. In addition, while amortization expense of acquisition-related intangible assets is excluded from Non-GAAP Net Income, the revenue generated from those assets is not excluded.

Restructuring charges or credits: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. Dolby excludes restructuring costs, including any adjustments to charges recorded in prior periods (which may be credits), as Dolby believes that these costs are not representative of its normal operating activities and therefore, excluding these amounts enables a more effective comparison of its past operating performance and to that of other companies.

Income tax adjustments: The income tax effects of the aforementioned non-GAAP adjustments do not directly correlate to its operating performance so Dolby believes that excluding such income tax effects provides a more meaningful view of its underlying operating results to management and investors.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby's business, including as a means to evaluate period-to-period comparisons. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.

Forward-Looking Statements

Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the fourth quarter of fiscal 2024 and full year fiscal 2024, Dolby's ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are "forward-looking statements" that inherently involve substantial risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of economic conditions on Dolby's business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; the level at which Dolby technologies are incorporated into products and the consumer demand for such products; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema market including adverse impact to Dolby's revenue recognized on box-office sales and demand for cinema products and services; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues and international conflicts; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee? pricing pressures? risks relating to changing trends in the way that content is distributed and consumed; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to maintaining patent coverage? the timing of Dolby's receipt of royalty reports and payments from its licensees, including recoveries? changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements? Dolby's ability to develop, maintain, and strengthen relationships with industry participants? Dolby's ability to develop and deliver innovative products and technologies in response to new and growing markets? competitive risks? risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights? risks associated with the health of the motion picture and cinema industries generally, including the continued impacts of the recent strikes by the WGA and SAG-AFTRA? Dolby's ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings? risks associated with acquiring and successfully integrating businesses or technologies? and other risks detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in its Quarterly Report on Form 10-Q filed on or around the date hereof. Dolby may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements. Forward-looking statements are based upon information available to us as of the date of such statements, and while Dolby believes such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by law, Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYSE: DLB) is based in San Francisco, California with offices around the globe. From movies and TV shows, to apps, music, sports and gaming, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide. Dolby partners with artists, storytellers, developers, and businesses to revolutionize entertainment and communications with Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby.io.

Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby.io, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in the United States and/or other countries. Other trademarks remain the property of their respective owners.


                                                                       
            
              DOLBY LABORATORIES, INC.

                                                            
            
         INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                                                                    
       (in thousands, except per share amounts; unaudited)




                                                                                                                                        Fiscal Quarter Ended               Fiscal Year-To-Date Ended


                                                                                                                               June 28,                      June 30,  June 28,                      June 30,
                                                                                                                                   2024                           2023       2024                           2023



     
              Revenue:



       Licensing                                                                                                              $267,082                       $273,108   $899,089                       $932,727



       Products and services                                                                                                    21,736                         25,262     69,826                         76,455



     Total revenue                                                                                                             288,818                        298,370    968,915                      1,009,182





     
              Cost of revenue:



       Cost of licensing                                                                                                        17,386                         15,610     48,440                         50,334



       Cost of products and services                                                                                            18,277                         25,905     58,060                         66,680



     Total cost of revenue                                                                                                      35,663                         41,515    106,500                        117,014





     
              Gross profit                                                                                                   253,155                        256,855    862,415                        892,168





     
              Operating expenses:



       Research and development                                                                                                 65,501                         68,696    195,027                        201,097



       Sales and marketing                                                                                                      77,518                         85,594    246,559                        263,494



       General and administrative                                                                                               69,275                         69,954    201,183                        191,865



       Restructuring charges                                                                                                     4,078                         16,676      7,674                         16,465



     Total operating expenses                                                                                                  216,372                        240,920    650,443                        672,921





     
              Operating income                                                                                                36,783                         15,935    211,972                        219,247





     
              Other income/(expense):



       Interest income/(expense), net                                                                                            9,439                          7,202     27,223                         18,806



       Other income, net                                                                                                         3,942                            620     13,550                          2,967



     Total other income                                                                                                         13,381                          7,822     40,773                         21,773





     Income before income taxes                                                                                                 50,164                         23,757    252,745                        241,020



     Provision for income taxes                                                                                               (10,509)                       (7,352)  (47,295)                      (49,284)



     Net income including noncontrolling interest                                                                               39,655                         16,405    205,450                        191,736



     Less: net income attributable to noncontrolling interest                                                                  (1,211)                           (6)   (2,195)                         (266)



     
              Net income attributable to Dolby Laboratories, Inc.                                                            $38,444                        $16,399   $203,255                       $191,470





     Net income per share:



     Basic                                                                                                                       $0.40                          $0.17      $2.13                          $2.00



     Diluted                                                                                                                     $0.40                          $0.17      $2.09                          $1.96



     Weighted-average shares outstanding:



     Basic                                                                                                                      95,686                         95,658     95,593                         95,794



     Diluted                                                                                                                    96,959                         97,459     97,412                         97,588


                                        
              
                DOLBY LABORATORIES, INC.

                             
              
                INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

                                              
              (in thousands; unaudited)




                                                                                                     June 28, September 29,
                                                                                                         2024           2023



     
                ASSETS



     Current assets:



     Cash and cash equivalents                                                                      $741,636       $745,364



     Restricted cash                                                                                  36,988         72,602



     Short-term investments                                                                          127,321        139,148



     Accounts receivable, net                                                                        285,843        262,245



     Contract assets, net                                                                            190,803        182,130



     Inventories, net                                                                                 34,716         35,623



     Prepaid expenses and other current assets                                                        51,348         50,692



     Total current assets                                                                          1,468,655      1,487,804



     Long-term investments                                                                           117,901         97,812



     Property, plant, and equipment, net                                                             477,686        481,581



     Operating lease right-of-use assets                                                              39,857         40,199



     Goodwill and intangible assets, net                                                             553,096        575,836



     Deferred taxes                                                                                  219,822        201,860



     Other non-current assets                                                                         96,618         94,674



     
                Total assets                                                                    $2,973,635     $2,979,766





     
                LIABILITIES AND STOCKHOLDERS' EQUITY



     Current liabilities:



     Accounts payable                                                                                $16,413        $20,925



     Accrued liabilities                                                                             280,611        351,399



     Income taxes payable                                                                             12,294          4,769



     Contract liabilities                                                                             32,650         31,505



     Operating lease liabilities                                                                      12,568         13,628



     Total current liabilities                                                                       354,536        422,226



     Non-current contract liabilities                                                                 35,647         39,997



     Non-current operating lease liabilities                                                          35,619         37,020



     Other non-current liabilities                                                                   100,401        108,339



     Total liabilities                                                                               526,203        607,582





     Stockholders' equity:



     Class A common stock                                                                                 53             53



     Class B common stock                                                                                 41             41



     Retained earnings                                                                             2,462,928      2,391,990



     Accumulated other comprehensive loss                                                           (30,172)      (36,984)



     Total stockholders' equity - Dolby Laboratories, Inc.                                         2,432,850      2,355,100



     Noncontrolling interest                                                                          14,582         17,084



     Total stockholders' equity                                                                    2,447,432      2,372,184



     
                Total liabilities and stockholders' equity                                      $2,973,635     $2,979,766


                                                                           
              
                DOLBY LABORATORIES, INC.

                                                            
              
                INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                                                 
              (in thousands; unaudited)




                                                                                                                                                     Fiscal Year-To-Date Ended


                                                                                                                                             June 28,                           June 30,
                                                                                                                                                 2024                                2023



     
                Operating activities:



     Net income including noncontrolling interest                                                                                           $205,450                            $191,736



     Adjustments to reconcile net income to net cash provided by operating activities:



       Depreciation and amortization                                                                                                          54,199                              61,428



       Stock-based compensation                                                                                                               90,146                              90,291



       Amortization of operating lease right-of-use assets                                                                                     8,745                               9,829



       Amortization of premium on investments                                                                                                (2,586)                              (179)



       Benefit from (provision for) credit losses                                                                                            (2,382)                              (348)



       Deferred income taxes                                                                                                                (18,009)                           (21,653)



       Other non-cash items affecting net income                                                                                             (6,181)                            (1,751)



       Changes in operating assets and liabilities:



       Accounts receivable, net                                                                                                             (21,319)                             43,546



       Contract assets, net                                                                                                                  (8,642)                           (10,105)



       Inventories                                                                                                                           (4,615)                            (2,425)



       Operating lease right-of-use assets                                                                                                   (7,681)                            (3,799)



       Prepaid expenses and other assets                                                                                                       7,527                                 775



       Accounts payable and accrued liabilities                                                                                             (80,837)                           (83,737)



       Income taxes, net                                                                                                                      15,265                              14,975



       Contract liabilities                                                                                                                  (3,189)                            (1,686)



       Operating lease liabilities                                                                                                           (2,577)                            (7,452)



       Other non-current liabilities                                                                                                        (12,232)                              2,621



     Net cash provided by operating activities                                                                                               211,082                             282,066





     
                Investing activities:



     Purchases of marketable securities                                                                                                    (147,646)                          (123,075)



     Proceeds from sales of marketable securities                                                                                              4,451                              54,020



     Proceeds from maturities of marketable securities                                                                                       140,839                             139,423



     Purchases of property, plant, and equipment                                                                                            (22,628)                           (22,154)



     Business combinations, net of cash and restricted cash acquired                                                                               -                             25,703



     Net cash provided by (used in) investing activities                                                                                    (24,984)                             73,917





     
                Financing activities:



     Proceeds from issuance of common stock                                                                                                   39,487                              37,231



     Repurchase of common stock                                                                                                            (139,999)                          (124,276)



     Payment of cash dividend                                                                                                               (85,971)                           (77,584)



     Distribution to noncontrolling interest                                                                                                 (4,507)                              (266)



     Shares repurchased for tax withholdings on vesting of restricted stock                                                                 (37,428)                           (28,619)



     Equity issued in connection with business combination                                                                                       722



     Payment of deferred consideration for prior business combinations                                                                             -                              (500)



     Net cash used in financing activities                                                                                                 (227,696)                          (194,014)





     Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash                                                    2,256                               8,819



     Net increase/(decrease) in cash, cash equivalents, and restricted cash                                                                 (39,342)                            170,788



     Cash, cash equivalents, and restricted cash at beginning of period                                                                      817,966                             628,371



     Cash, cash equivalents, and restricted cash at end of period                                                                           $778,624                            $799,159


                                             
              
                Licensing Revenue by Market

                                                     
              
                (unaudited)





     The following table presents the composition of our licensing revenue for all periods presented (in thousands, except percentage amounts):




                                                                              Fiscal Quarter Ended                                Fiscal Year-To-Date Ended


                                  Market                                      June 28, 2024                                June 30, 2023                            June 28, 2024 June 30, 2023



     Broadcast                                            $95,430      36 %            $102,966      38 %            $313,326      35 %              $349,271  37 %



     Mobile                                                63,096      24 %              50,363      18 %             187,073      21 %               207,775  22 %



     CE                                                    28,352      11 %              34,417      13 %             123,793      14 %               128,515  14 %



     PC                                                    27,606      10 %              29,489      11 %             107,223      12 %                97,122  10 %



     Other                                                 52,598      19 %              55,873      20 %             167,674      18 %               150,044  17 %


                   Total licensing revenue                $267,082     100 %            $273,108     100 %            $899,089     100 %              $932,727 100 %



     
                
                  GAAP to Non-GAAP Reconciliations



     
                
                  (unaudited)





     The following tables present Dolby's GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the third quarter and year-to-date periods ended June 28, 2024 and June 30, 2023:





     
                
                  Net income:                                                                                                                                                                                   Fiscal Quarter Ended                Fiscal Year-To-Date Ended



     
                
                  (in thousands)                                                                                                                                                                                June 28,                  June 30,    June 28,                      June 30,
                                                                                                                                                                                                                                    2024                       2023         2024                              2023



     GAAP net income attributable to Dolby Laboratories, Inc.                                                                                                                                                                   $38,444                    $16,399     $203,255                          $191,470



     Stock-based compensation (1)                                                                                                                                                                                                29,337                     29,224       90,146                            90,291



     Amortization of acquisition-related intangibles (2)                                                                                                                                                                          3,101                      3,031        9,256                             6,750



     Restructuring charges                                                                                                                                                                                                        4,078                     16,676        7,674                            16,465



     Income tax adjustments                                                                                                                                                                                                     (6,210)                  (11,255)    (19,751)                         (20,910)



     Non-GAAP net income attributable to Dolby Laboratories, Inc.                                                                                                                                                               $68,750                    $54,075     $290,580                          $284,066





     (1) Stock-based compensation included in above line items:



       Cost of products and services                                                                                                                                                                                               $373                       $375       $1,139                            $1,309



       Research and development                                                                                                                                                                                                   9,456                      9,681       28,511                            29,829



       Sales and marketing                                                                                                                                                                                                        9,726                      9,756       30,134                            30,759



       General and administrative                                                                                                                                                                                                 9,782                      9,412       30,362                            28,394





     (2) Amortization of acquisition-related intangibles included in above line items:



       Cost of licensing                                                                                                                                                                                                            $54                        $62         $101                              $185



       Cost of products and services                                                                                                                                                                                                524                        866        1,582                             2,599



       Research and development                                                                                                                                                                                                                                                                            254



       Sales and marketing                                                                                                                                                                                                          651                        806        1,957                             2,415



       General and administrative                                                                                                                                                                                                 1,872                      1,297        5,616                             1,297





     
                
                  Diluted earnings per share:                                                                                                                                                                   Fiscal Quarter Ended                Fiscal Year-To-Date Ended


                                                                                                                                                                                                                                June 28,                  June 30,    June 28,                      June 30,
                                                                                                                                                                                                                                    2024                       2023         2024                              2023



     GAAP diluted earnings per share                                                                                                                                                                                              $0.40                      $0.17        $2.09                             $1.96



     Stock-based compensation                                                                                                                                                                                                      0.30                       0.30         0.93                              0.93



     Amortization of acquisition-related intangibles                                                                                                                                                                               0.03                       0.03         0.09                              0.06



     Restructuring charges                                                                                                                                                                                                         0.04                       0.17         0.07                              0.17



     Income tax adjustments                                                                                                                                                                                                      (0.06)                    (0.12)      (0.20)                           (0.21)



     Non-GAAP diluted earnings per share                                                                                                                                                                                          $0.71                      $0.55        $2.98                             $2.91







     Weighted-average shares outstanding - diluted (in thousands)                                                                                                                                                                96,959                     97,459       97,412                            97,588











     The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial measures for the fourth quarter of fiscal 2024 and full year fiscal 2024 included in this release:





     
                
                  Operating expenses (in millions):                                                                                                                                                                                       Q4 2024                                   Fiscal 2024



     GAAP operating expenses (low - high end of range)                                                                                                                                                                                              
     $225 - $235                            
         $875 - $885



     Stock-based compensation                                                                                                                                                                                                                                (31)                                        (120)



     Amortization of acquisition-related intangibles                                                                                                                                                                                                          (4)                                         (12)



     Restructuring charges                                                                                                                                                                                                                                                                                 (8)



     Non-GAAP operating expenses (low - high end of range)                                                                                                                                                                                          
     $190 - $200                            
         $735 - $745





     
                
                  Operating margin:                                                                                                                                                                                                                                               Fiscal 2024



     GAAP operating margin                                                                                                                                                                                                                                                                     
           20% +/-



     Stock-based compensation                                                                                                                                                                                                                                                                              9 %



     Amortization of acquisition-related intangibles                                                                                                                                                                                                                                                       1 %



     Restructuring charges                                                                                                                                                                                                                                                                                 1 %



     Non-GAAP operating margin                                                                                                                                                                                                                                                                 
           31% +/-









     
                
                  Effective tax rate:                                                                                                                                                                                                                                               Q4 2024



     GAAP effective tax rate                                                                                                                                                                                                                                                                              29 %



     Stock-based compensation (low - high end of range)                                                                                                                                                                                                                                              (5%) - 1%



     Amortization of acquisition-related intangibles (low - high end of range)                                                                                                                                                                                                                       (2%) - 0%



     Non-GAAP effective tax rate                                                                                                                                                                                                                                                                          23 %





     
                
                  Diluted earnings per share:                                                                                                                                                                   Q4 2024                             Fiscal 2024


                                                                                                                                                                                                                                Low                       High        Low                           High



     GAAP diluted earnings per share                                                                                                                                                                                              $0.31                      $0.46        $2.40                             $2.55



     Stock-based compensation                                                                                                                                                                                                      0.31                       0.31         1.23                              1.23



     Amortization of acquisition-related intangibles                                                                                                                                                                               0.03                       0.03         0.13                              0.13



     Restructuring charges                                                                                                                                                                                                                                               0.08                              0.08



     Income tax adjustments                                                                                                                                                                                                      (0.04)                    (0.04)      (0.24)                           (0.24)



     Non-GAAP diluted earnings per share                                                                                                                                                                                          $0.61                      $0.76        $3.60                             $3.75





     Weighted-average shares outstanding - diluted (in thousands)                                                                                                                                                                97,000                     97,000       97,200                            97,200

Investor Contact:
Peter Goldmacher
415-254-7415
peter.goldmacher@dolby.com

Media Contact:
media@dolby.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/dolby-laboratories-reports-third-quarter-2024-financial-results-302217083.html

SOURCE Dolby Laboratories, Inc.